Sort
30,917 grants matching “tumor microenvironment”
A novel oncolytic virus for pancreatic cancer immunotherapy
$249,900Omeed Moaven · Lsu Health Sciences Center · P20 · FY2024 · GM
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib
$249,853Evan Todd Keller · University Of Michigan At Ann Arbor · P50 · FY2015 · CA
Hypoxia, HIF and Tumorigenesis
$249,846Jaime Caro · Thomas Jefferson University · R01 · FY2008 · CA
Hypoxia, HIF and Tumorigenesis
$249,846Jaime Caro · Thomas Jefferson University · R01 · FY2009 · CA
Hypoxia, HIF and Tumorigenesis
$249,846Jaime Caro · Thomas Jefferson University · R01 · FY2007 · CA
Contribution of Epithelial-stromal Interactions to Human Breast Tumor Heterogenei
$249,834Morag Park · Ohio State University · P01 · FY2014 · CA
A multimodal single-cell approach to developing personalized combinatorial treatments for glioblastoma
$249,832Allegra Adele Petti · Massachusetts General Hospital · R21 · FY2024 · CA
Mechanisms of KSHV-Induced Cellular Transformation
$249,814Ashlee V Moses · Oregon Health & Science University · R01 · FY2011 · CA
Targeting the Tumor Microenvironment in Patients with AIDS-Associated EBV+ Diffuse Large B Cell Lymphoma
$249,809Raphael E. Pollock · Ohio State University · P30 · FY2024 · CA
Cancer Center Support Grant
$249,783Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2018 · CA
Tumor Progression and Metastasis
$249,760Jeffrey W. Pollard · Albert Einstein College Of Medicine · P01 · FY2009 · CA
Validated Modeling and Culture of Salivary Cancers
$249,750Wendell G Yarbrough · Yale University · R21 · FY2014 · DE
Facilitation of Autologous Hematopoietic Stem Cell Engraftment for Gene Therapy
$249,705Julian David Down · Genetix Pharmaceuticals, Inc. · R43 · FY2008 · HL
Scr as a Therapeutic Target in Prostate Cancer Bone Metastases
$249,662Gary E Gallick · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Core 2: Theory Core - Multiscale models for mechano-chemical phenomena
$249,650Andrea Liu · University Of Pennsylvania · U54 · FY2019 · CA
Defining the impact of mutational drivers on the immune microenvironment of CLL
$249,645Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R21 · FY2022 · CA
Non-receptor protein tyrosine phosphatases in macrophage-mediated cancer cell phagocytosis.
$249,645Mingye Feng · Beckman Research Institute/City Of Hope · R21 · FY2025 · CA
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer
$249,645Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2025 · CA
Advanced Genetic Engineering to Unravel Tumor-Specific B Cell Responses
$249,645Pietro Genovese · Boston Children'S Hospital · R21 · FY2025 · CA
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
$249,638Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2018 · CA
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
$249,638Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2020 · CA
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
$249,637Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2016 · CA
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
$249,637Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2017 · CA
Core Support for Cancer Center
$249,624Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2011 · CA
Core Support for Cancer Center
$249,624Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2011 · CA